Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)

Clinical trial NCT06030193 · COMPLETED

Trial details

NCT number: NCT06030193
Sponsor: Qlaris Bio, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Normal Tension Glaucoma (NTG)Low-Tension Glaucoma, Bilateral Low-Tension Glaucoma, Unspecified Eye Glaucoma

Start date: 2025-08-13
Primary completion: 2026-02-23
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.